Bioavailability of Levoketoconazole and Ketoconazole Tablets
Status:
Completed
Trial end date:
2020-01-23
Target enrollment:
Participant gender:
Summary
This is a phase 1, randomized, open-label, single-dose, two-period, two-sequence crossover
study in healthy male and female subjects to evaluate the relative oral bioavailability of
levoketoconazole tablets (the test drug) and ketoconazole tablets (the reference drug
product).